Doug Love
President and Chief Executive Officer
Replay available
Annexon, Inc. (ANNX) Q2 2026 Earnings Call
Annexon, Inc. (NASDAQ: ANNX) Q2 2026 earnings conference call, held 2026-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Jamie Dannenberg
EVP and Chief Medical Officer
Dr. Lloyd Clark
SVP of Ophthalmology Strategy and Innovation
Anupam Rama
Analyst at JPMorgan
Derek Garcia
Analyst at Wells Fargo
Matt Barkis
Analyst at Jefferies
Salveen Richter
Analyst at Goldman Sachs
Joey Stringer
Analyst at Needham
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Annexon, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0414b-c752-7230-949f-6ee6a8fdbf74 Created: 2026-08-27T03:38:03.060Z Duration: 2358.432 Channels: 1 00:00:00.000 -- 00:00:02.000 Good morning, everyone, and welcome to the ANNX 00:00:02.000 -- 00:00:04.799 on business update call. At this time, all 00:00:04.799 -- 00:00:06.640 attendees are in a listen only mode, and 00:00:06.640 -- 00:00:08.400 a question and answer session will follow the 00:00:08.400 -- 00:00:11.040 formal remarks. As a reminder, this call is 00:00:11.040 -- 00:00:12.880 being recorded, and a replay will be made 00:00:12.880 -- 00:00:14.799 available on the ANNX on website following the 00:00:14.799 -- 00:00:16.635 conclusion of the event. I'd now like to 00:00:16.635 -- 00:00:18.475 turn the call over to Doug Love, president 00:00:18.475 -- 00:00:20.875 and chief executive officer of ANNXON. Please go 00:00:20.875 -- 00:00:21.675 ahead, Doug. 00:00:22.075 -- 00:00:24.875 Thank you, operator. Good morning, and welcome, everyone. 00:00:24.955 -- 00:00:27.595 Earlier this morning, ANNXON issued a press release 00:00:27.595 -- 00:00:30.330 announcing that we have expanded our ARCHER II 00:00:30.330 -- 00:00:33.610 Phase III trial for vodipruma in geographic atrophy 00:00:33.690 -- 00:00:36.250 and a press release announcing key business updates 00:00:36.250 -- 00:00:38.410 and second quarter financial results. 00:00:38.810 -- 00:00:40.810 Copies of these press releases are available on 00:00:40.810 -- 00:00:43.450 the company's website and through our SEC filings. 00:00:44.115 -- 00:00:46.115 On today's call, we will be making forward 00:00:46.115 -- 00:00:49.075 looking statements, including statements relating to the existing 00:00:49.075 -- 00:00:50.115 clinical data 00:00:50.355 -- 00:0...